Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adenocarcinoma (PDAC)

BACKGROUND: Delayed diagnosis and treatment worsen survival in pancreatic ductal adenocarcinoma (PDAC). Despite many potential causes, the influence of social determinants of health (SDoH) is understudied. We evaluated whether SDoH impact delays in diagnosis and treatment among patients who underwent resection for PDAC. PATIENTS AND METHODS: Adults resected at a high-volume center were included (January 2016-November 2024). SDoH included insurance status, census-level income and education, rural-urban residence, and Area Deprivation Index. Primary endpoints were time from first imaging to histological diagnosis and time from first imaging to treatment initiation. Delay thresholds were derived using receiver operating characteristic analysis against overall survival. Uni- and multivariable logistic regression identified factors associated with delays, adjusting for demographic and clinical covariates, stratified by outpatient (OUP) versus emergency room (ER) presentation. RESULTS: Among 317 patients, the median age was 67 years, and 42.3% were female; 50.1% presented through ER. The median imaging-to-diagnosis interval was 11 days (interquartile [IQR] 3-27 days), and the median imaging-to-treatment interval was 40 days (IQR 27-59 days). In the OUP cohort, Medicare insurance was associated with delayed diagnosis compared with private insurance (OR 3.34 [95% CI 1.09-11.70]), whereas higher income was associated with up to 84% lower odds of delayed treatment. In the ER cohort, higher education was associated with reduced odds of delayed diagnosis (OR 0.27 [95% CI 0.07-0.88]) and delayed treatment (OR 0.33 [95% CI 0.11-0.91]). Post-endoscopic retrograde cholangiopancreatography (ERCP) hospitalization predicted delays in the ER setting, whereas alarm symptoms reduced delays in both settings. CONCLUSIONS: SDoH are associated with diagnostic and treatment delays in resected PDAC. Targeted interventions may accelerate care and improve equity in outcomes.

Authors

Institutions

Publication Details

Journal
Annals of Surgical Oncology
Published
2026-10-14
DOI
https://doi.org/10.1245/s10434-026-20419-4
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Noelle K. LoConte, Clayton Thomas Marcinak, Syed Nabeel Zafar, Patrick R. Varley et al.
Annals of Surgical Oncology
Pancreatic and Hepatic Oncology Research
article

Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Noelle K. LoConte, Clayton Thomas Marcinak, Syed Nabeel Zafar, Patrick R. Varley, Muhammad Maisam Ali, Manar Z Al Rubaye, Yazan M. Hammad, Ping Zhu, Kamran Idrees, Benjamin AY Cher
article en

Abstract

BACKGROUND: Delayed diagnosis and treatment worsen survival in pancreatic ductal adenocarcinoma (PDAC). Despite many potential causes, the influence of social determinants of health (SDoH) is understudied. We evaluated whether SDoH impact delays in diagnosis and treatment among patients who underwent resection for PDAC. PATIENTS AND METHODS: Adults resected at a high-volume center were included (January 2016-November 2024). SDoH included insurance status, census-level income and education, rural-urban residence, and Area Deprivation Index. Primary endpoints were time from first imaging to histological diagnosis and time from first imaging to treatment initiation. Delay thresholds were derived using receiver operating characteristic analysis against overall survival. Uni- and multivariable logistic regression identified factors associated with delays, adjusting for demographic and clinical covariates, stratified by outpatient (OUP) versus emergency room (ER) presentation. RESULTS: Among 317 patients, the median age was 67 years, and 42.3% were female; 50.1% presented through ER. The median imaging-to-diagnosis interval was 11 days (interquartile [IQR] 3-27 days), and the median imaging-to-treatment interval was 40 days (IQR 27-59 days). In the OUP cohort, Medicare insurance was associated with delayed diagnosis compared with private insurance (OR 3.34 [95% CI 1.09-11.70]), whereas higher income was associated with up to 84% lower odds of delayed treatment. In the ER cohort, higher education was associated with reduced odds of delayed diagnosis (OR 0.27 [95% CI 0.07-0.88]) and delayed treatment (OR 0.33 [95% CI 0.11-0.91]). Post-endoscopic retrograde cholangiopancreatography (ERCP) hospitalization predicted delays in the ER setting, whereas alarm symptoms reduced delays in both settings. CONCLUSIONS: SDoH are associated with diagnostic and treatment delays in resected PDAC. Targeted interventions may accelerate care and improve equity in outcomes.

Annals of Surgical Oncology
University of Wisconsin–Madison (US), Vanderbilt University (US), Vanderbilt University Medical Center (US)
National Institutes of Health, National Cancer Institute
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 76%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.